Literature DB >> 1682000

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation.

A S Freeman1, L A Chiodo, S I Lentz, K Wade, M J Bannon.   

Abstract

Cholecystokinin octapeptide (CCK-8) is colocalized within a majority of dopamine (DA)-containing neurons of the rat midbrain. Exogenous CCK-8 can modulate the electrophysiological activity of DA neurons, at least in part, by direct actions on the somatodendritic region of these cells. If CCK-8 is somatodendritically released from DA neurons, it may influence DA cell function as has been shown for DA itself. In the present study, radioimmunoassay was used to determine if CCK-8 is released in vitro from slices of rat midbrain under basal and depolarizing (30 mM potassium) conditions. Low levels of CCK-8 were detected in the basal incubation medium. Thirty mM potassium caused about a 3-fold increase in the release of CCK-8. This stimulated release was abolished in calcium-free medium. The D2 receptor agonist quinpirole, but not the D1 agonist SKF 38393, attenuated the potassium-stimulated release of CCK-8 but did not affect basal release. These results show that CCK-8, like DA, can be released from midbrain slices, presumably from DA/CCK-8-containing neurons. This finding is in accordance with the possibility that CCK-8 plays a role in the regulation of DA neuronal function at the level of the cell body, where it might influence the excitability of the DA cell membrane.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682000     DOI: 10.1016/0006-8993(91)90353-w

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.

Authors:  Mitsuko Hamamura; Hidetoshi Ozawa; Miwako Ozaki; Takao Shimazoe; Yoshihiro Terada; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2010-08-03       Impact factor: 3.575

2.  A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin.

Authors:  R Pietrowsky; A Thiemann; W Kern; H L Fehm; J Born
Journal:  Psychoneuroendocrinology       Date:  1996-08       Impact factor: 4.905

3.  Transcriptional activation of the cholecystokinin gene by DJ-1 through interaction of DJ-1 with RREB1 and the effect of DJ-1 on the cholecystokinin level in mice.

Authors:  Takuya Yamane; Sayaka Suzui; Hirotake Kitaura; Kazuko Takahashi-Niki; Sanae M M Iguchi-Ariga; Hiroyoshi Ariga
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.